| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1050/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1050 |
| Version | 20240123 |
| Status | active |
| Date | 2024-01-23T01:10:32-05:00 |
| Name | PotentiallyHarmfulGastrointestinalAntispasmodicsForOlderAdults |
| Title | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Gastrointestinal Antispasmodics for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes atropine, chlordiazepoxide-clidinium, dicyclomine, hyoscyamine, and scopolamine. Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes ophthalmic routes.) |
No resources found
| CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm  | RxNorm |
| http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1254 | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.464.1003.1050",
"meta" : {
"versionId" : "16",
"lastUpdated" : "2024-01-24T09:18:12.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "NCQA PHEMUR Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-01-23"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-01-23"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1050",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.464.1003.1050"
}
],
"version" : "20240123",
"name" : "PotentiallyHarmfulGastrointestinalAntispasmodicsForOlderAdults",
"title" : "Potentially Harmful Gastrointestinal Antispasmodics for Older Adults",
"status" : "active",
"date" : "2024-01-23T01:10:32-05:00",
"publisher" : "NCQA PHEMUR",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Gastrointestinal Antispasmodics for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes atropine, chlordiazepoxide-clidinium, dicyclomine, hyoscyamine, and scopolamine. Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes ophthalmic routes.)",
"compose" : {
"include" : [
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1254"
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:68f9057f-ea1d-4cd2-bd98-f980f97b9477",
"timestamp" : "2024-12-10T10:30:45-05:00",
"total" : 41,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1037234",
"display" : "benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1046770",
"display" : "12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1046787",
"display" : "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1046815",
"display" : "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1046982",
"display" : "hyoscyamine sulfate 0.125 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1046985",
"display" : "hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1046997",
"display" : "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1047786",
"display" : "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1047881",
"display" : "hyoscyamine sulfate 0.025 MG/ML Oral Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1047895",
"display" : "hyoscyamine sulfate 0.125 MG/ML Oral Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1047905",
"display" : "hyoscyamine sulfate 0.125 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1047916",
"display" : "1 ML hyoscyamine sulfate 0.5 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1048124",
"display" : "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1048307",
"display" : "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1048336",
"display" : "hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1050325",
"display" : "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1087365",
"display" : "hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190538",
"display" : "0.7 ML atropine sulfate 0.714 MG/ML Auto-Injector"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190540",
"display" : "0.7 ML atropine sulfate 1.43 MG/ML Auto-Injector"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190542",
"display" : "0.7 ML atropine sulfate 2.86 MG/ML Auto-Injector"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190546",
"display" : "10 ML atropine sulfate 0.1 MG/ML Prefilled Syringe"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190551",
"display" : "5 ML atropine sulfate 0.05 MG/ML Prefilled Syringe"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190552",
"display" : "5 ML atropine sulfate 0.1 MG/ML Prefilled Syringe"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190568",
"display" : "atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190572",
"display" : "atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190738",
"display" : "atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190748",
"display" : "5 ML atropine sulfate 0.14 MG/ML / edrophonium chloride 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190776",
"display" : "atropine sulfate 0.4 MG/ML Injectable Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1190795",
"display" : "1 ML atropine sulfate 1 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1440869",
"display" : "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1666781",
"display" : "1 ML atropine sulfate 0.4 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1807886",
"display" : "Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "226552",
"display" : "72 HR scopolamine 0.0139 MG/HR Transdermal System"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2637557",
"display" : "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "727415",
"display" : "2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "889614",
"display" : "chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "991061",
"display" : "dicyclomine hydrochloride 10 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "991065",
"display" : "2 ML dicyclomine hydrochloride 10 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "991082",
"display" : "dicyclomine hydrochloride 2 MG/ML Oral Solution"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "991086",
"display" : "dicyclomine hydrochloride 20 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "998726",
"display" : "hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.